Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 23 de feb. de 2023 · Calcium channel blockers (CCBs) are medications that treat high blood pressure and other heart-related health conditions. Common CCB side effects include constipation, swelling in the arms and legs, and a slow heart rate. Fatigue, flushing, and dizziness can also occur. CCBs can cause worsening of heart problems, such as heart failure.

  2. 11 de jul. de 2022 · Calcium channel blockers are one type. They treat AFib by slowing your heart rate and relaxing the heart muscle so it doesn't have to work as hard. AFib also raises your risk for heart failure ...

  3. 11 de ene. de 2017 · The calcium channel blockers act by blocking the influx of calcium ions into vascular smooth muscle and cardiac muscle cells during membrane depolarization. Because muscle contraction is largely dependent upon influx of calcium, its inhibition causes relaxation, particularly in arterial beds. Thus, …

  4. 14 de sept. de 2023 · Calcium channel blockers reduce the amount of calcium that goes into these muscle cells. This causes these muscle cells to relax. So, the effects of these medicines are: Reduces the blood pressure. Helps to treat angina by widening the coronary arteries. Can ease symptoms of Raynaud's phenomenon.

  5. 28 de dic. de 2023 · Bloqueadores de los canales de calcio. Estos medicamentos reducen la presión arterial y tratan otras afecciones como el dolor en el pecho y los latidos cardíacos irregulares. Los antagonistas del calcio son medicamentos utilizados para reducir la presión arterial. Impiden que el calcio penetre en las células del corazón y las arterias.

  6. 10 de mar. de 2022 · While calcium channel blockers are effective drugs against a wide array of cardiac diseases, they have been reported to have various adverse effects such as headaches, lightheadedness, peripheral edema, constipation, and bradycardia, among others. Hence, there is a further need to optimize the pharmacology of these drugs.

  7. 29 de may. de 2017 · Calcium channel blockers do not cause sodium retention, an undesired effect that is observed with vasodilators including α-blockers, hydralazine, and minoxidil. By contrast, CCBs increase sodium excretion when administered acutely to hypertensive humans and animals ( Kazda and Knorr, 1990 ).